Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beneficient (BENF) Cash & Equivalents (2022 - 2025)

Beneficient's Cash & Equivalents history spans 4 years, with the latest figure at $7.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 89.61% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $7.9 million, up 89.61%, while the annual FY2025 figure was $1.3 million, 82.99% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $7.9 million at Beneficient, up from $4.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $70.6 million in Q1 2022 and bottomed at $1.3 million in Q1 2025.
  • The 4-year median for Cash & Equivalents is $4.9 million (2025), against an average of $10.7 million.
  • The largest annual shift saw Cash & Equivalents plummeted 87.64% in 2023 before it surged 89.61% in 2025.
  • A 4-year view of Cash & Equivalents shows it stood at $70.6 million in 2022, then tumbled by 84.13% to $11.2 million in 2023, then tumbled by 62.96% to $4.1 million in 2024, then soared by 89.61% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for BENF's Cash & Equivalents are $7.9 million (Q4 2025), $4.9 million (Q3 2025), and $7.6 million (Q2 2025).